Skip to main content
  • Meeting abstract
  • Open access
  • Published:

NMDA receptor dependent anti-diabetic effects


In the central nervous system, NMDA receptors play a pivotal role, however, their role in pancreatic islets has been largely unexplored or is controversial. We hypothesized that NMDA receptors are involved in glucose stimulated insulin secretion from beta cells and might serve as novel drug targets for diabetes treatment.


We generated mice with a pancreas-specific deletion of all NMDA receptors. The phenotype of these mice and their pancreatic islets were characterized in terms of insulin secretion, glucose tolerance and calcium oscillations. We also pharmacologically inhibited the NMDA receptors in vitro and in vivo. Subsequently, insulin secretion from isolated mouse and human islets as well as blood glucose and plasma insulin concentrations were analyzed in mice and via a clinical trial in type 2 diabetic patients.


Functional NMDA receptors are expressed in insulin producing cells. A pancreas specific NMDA receptor knockout selectively increases glucose stimulated insulin secretion in vitro and improves glucose tolerance in vivo. The pharmacological inhibition of NMDA receptors selectively increases glucose stimulated insulin secretion in vitro and improves glucose tolerance in C57Bl/6 and diabetic mice. In addition, we performed a clinical trial in patients with type 2 diabetes and provided evidence that the NMDA receptor antagonist Dextromethorphan (DXM) lowers blood glucose levels and increases insulin secretion without the risk of hypoglycemia.


We show for the first time that NMDA receptors can be targeted genetically and pharmacologically in mice and men to selectively increase glucose stimulated insulin secretion with improvement of glucose tolerance. We uncovered a new role for NMDA receptors in the pancreas and showed that inhibiting these receptors might serve as a useful treatment of human diabetes in pediatric and adult patients.

Author information

Authors and Affiliations


Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Marquard, J., Otter, S., Welters, A. et al. NMDA receptor dependent anti-diabetic effects. Mol Cell Pediatr 1 (Suppl 1), A26 (2014).

Download citation

  • Published:

  • DOI: